Kingdom Financial Group LLC. Makes New $578,000 Investment in Aflac Incorporated $AFL

Kingdom Financial Group LLC. bought a new position in shares of Aflac Incorporated (NYSE:AFL) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 5,239 shares of the financial services provider’s stock, valued at approximately $578,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AFL. BIP Wealth LLC increased its stake in Aflac by 348.3% during the 4th quarter. BIP Wealth LLC now owns 55,723 shares of the financial services provider’s stock worth $6,145,000 after purchasing an additional 43,293 shares in the last quarter. ProShare Advisors LLC increased its stake in Aflac by 10.4% during the 3rd quarter. ProShare Advisors LLC now owns 1,731,482 shares of the financial services provider’s stock worth $193,407,000 after purchasing an additional 163,791 shares in the last quarter. Wedbush Securities Inc. increased its stake in Aflac by 126.1% during the 3rd quarter. Wedbush Securities Inc. now owns 21,345 shares of the financial services provider’s stock worth $2,384,000 after purchasing an additional 11,903 shares in the last quarter. Nordea Investment Management AB increased its stake in Aflac by 5.5% during the 4th quarter. Nordea Investment Management AB now owns 1,866,471 shares of the financial services provider’s stock worth $206,712,000 after purchasing an additional 97,766 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its stake in Aflac by 12.0% during the 3rd quarter. Jones Financial Companies Lllp now owns 97,344 shares of the financial services provider’s stock worth $10,841,000 after purchasing an additional 10,423 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on AFL shares. Piper Sandler lowered their target price on Aflac from $130.00 to $125.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Wells Fargo & Company dropped their price target on Aflac from $116.00 to $111.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 5th. Wall Street Zen raised Aflac from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings raised Aflac from a “buy (b-)” rating to a “buy (a-)” rating in a research note on Friday, May 15th. Finally, UBS Group dropped their price target on Aflac from $116.00 to $114.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Aflac currently has a consensus rating of “Hold” and an average target price of $111.82.

Insider Activity

In related news, Director Thomas J. Kenny sold 1,740 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $116.57, for a total transaction of $202,831.80. Following the transaction, the director directly owned 13,219 shares of the company’s stock, valued at approximately $1,540,938.83. The trade was a 11.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Arthur Reginald Collins sold 2,300 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $116.55, for a total value of $268,065.00. Following the transaction, the director directly owned 6,186 shares in the company, valued at $720,978.30. The trade was a 27.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 782,428 shares of company stock valued at $88,097,875 in the last 90 days. 0.80% of the stock is owned by company insiders.

Aflac Stock Performance

Shares of NYSE AFL opened at $117.74 on Friday. The stock has a 50 day moving average price of $112.32 and a 200 day moving average price of $111.60. Aflac Incorporated has a 52 week low of $96.95 and a 52 week high of $119.81. The stock has a market capitalization of $59.93 billion, a PE ratio of 13.36, a price-to-earnings-growth ratio of 2.04 and a beta of 0.62. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.11 and a current ratio of 0.11.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, April 29th. The financial services provider reported $1.75 EPS for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The firm had revenue of $4.24 billion during the quarter, compared to the consensus estimate of $4.20 billion. Aflac had a net margin of 25.60% and a return on equity of 13.88%. The business’s revenue was up 27.9% on a year-over-year basis. During the same period last year, the business earned $1.66 EPS. Analysts predict that Aflac Incorporated will post 7.12 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Wednesday, May 20th will be issued a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Wednesday, May 20th. Aflac’s dividend payout ratio is presently 27.70%.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.